Candriam Equities L Biotechnology Class R2 Fonds
251,13
USD
-1,16
USD
-0,46
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 6,27% |
| Amgen Inc | US0311621009 | 5,76% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 5,53% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,98% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,75% |
| BioNTech SE ADR | US09075V1026 | 3,85% |
| argenx SE | NL0010832176 | 2,90% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,75% |
| Insmed Inc | US4576693075 | 2,68% |
| UCB SA | BE0003739530 | 2,22% |
| Sonstige | 58,31% |